COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
– In Q1 following a development achievement, CollPlant received a $2 million payment from AbbVie – – Advancement of regenerative breast implant program... Read more.
Luna Atoms’ The Future: An AI-Powered Pop Rebellion Uniting Humanity
Debut Indie-Pop Album The Future Challenges Influencer Culture LONDON, May 28, 2025 /PRNewswire/ — In a world where fame is a glitch and influencers sell... Read more.
GTCR Announces Sale of Antylia Scientific
Transaction Follows Decade-Long Management Partnership Culminating in Successful Transformation and Growth of Unique Life Sciences Tools Business CHICAGO, May 28,... Read more.
AKTIS ONCOLOGY INITIATES PHASE 1B CLINICAL TRIAL OF ITS NECTIN-4-TARGETING RADIOPHARMACEUTICAL PRODUCT CANDIDATE, AKY-1189, ACROSS MULTIPLE TUMOR TYPES
US FDA cleared INDs for Ac-AKY-1189 and Cu-AKY-1189 for initiation of broad NECTINIUM-2 Phase 1b trial NECTINIUM-2 will evaluate Ac-AKY-1189 for the treatment of... Read more.
PNRI Podcast Explores How Rare Disease Research Is Reshaping Medicine for All
SEATTLE, May 28, 2025 /PRNewswire/ — The answers to some of medicine’s biggest challenges are hiding in the rarest of diseases. A new podcast from Pacific... Read more.
HONEYWELL APPOINTS MARC STEINBERG TO BOARD OF DIRECTORS
CHARLOTTE, N.C., May 28, 2025 /PRNewswire/ — Honeywell (NASDAQ: HON) announced today that its Board of Directors has elected Marc Steinberg, a Partner at Elliott... Read more.
ATI signs multi-year agreement with Airbus for titanium plate, sheet and billet
Positions ATI as a top supplier to Airbus of titanium flat rolled and long products DALLAS, May 28, 2025 /PRNewswire/ — ATI Inc. (NYSE: ATI) is pleased to... Read more.
Hillstar Bio Appoints Maude Tessier, Ph.D., as Chief Operating Officer and Expands Leadership Team to Advance Pipeline of Precision Immunotherapies
Shiva Krupa, Ph.D., MBA, also joins as Vice President of Program Management BOSTON, May 28, 2025 /PRNewswire/ — Hillstar Bio, a leading biotechnology company... Read more.
Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy at the ASGCT 28th Annual Meeting
Novel Gene Therapy is Addressing Both Type 1 and Type 2 Diabetes AUSTIN, Texas, May 28, 2025 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”)... Read more.
Eventus, Datos Insights release new trade surveillance report highlighting increased AI adoption, rising demand for cross-asset, holistic surveillance strategies
New study reveals continued high false-positive rates along with data, technology and talent gaps across global capital markets AUSTIN, Texas and BOSTON, May 28,... Read more.